Business
Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials
Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials.
About this update from Nemaura Medical, Inc.
[{"type":"text","content":"\n \n Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused \n on the development and commercialization of sugarBEAT®, a wireless \n adhesive skin-patch for adjunctive use by diabetics as a non-invasive \n and needle-free glucose monitoring system today announced interim \n clinical trial results for the sugarBEAT® European clinical trial \n programme.\n \n \n This clinical trial programme consists of a total of 525 patient days, \n comprising 75 patients continuously wearing sugarBEAT® for up to 14 \n hours per day over 7 consecutive days in a combination of home and \n clinic settings. The trials are expected to determine safety, accuracy, \n precision and utility of sugarBEAT® as an adjunct to finger stick \n testing, and is expected to be completed over the next ten weeks.\n \n \n Interim results based on 175 patient days completed thus far have \n detected no skin irritation or serious adverse events. Minor adverse \n events were reported in the form of skin-patch de-lamination due to high \n humidity weather conditions, and were addressed by using an over-strip \n of adhesive or use of elastic arm band. Nemaura anticipates launching \n sugarBEAT® in the UK shortly after completion of this clinical trial \n programme.\n \n \n The data generated thus far has indicated accuracy that is comparable \n to, and non-inferior to that previously achieved by the wired wrist worn \n predecessor SugarBEAT® device, which received a CE mark in 2016.\n \n \n SugarBEAT® consists of a disposable skin-patch connected to a \n rechargeable transmitter, with a mobile app displaying glucose readings \n at regular five minute intervals.\n \n \n Further clinical studies are planned including those for FDA approval in \n the US, and to investigate the use of sugarBEAT® in critical care \n settings.\n \n \n About Nemaura Medical, Inc.\n \n \n Nemaura Medical is a medical technology company developing the wireless \n sugarBEAT® disposable adhesive skin-patch as a non-invasive, \n needle-free, pain-free and affordable glucose monitoring system for \n adjunctive use by diabetics. For more information, please visit www.nemauramedical.com.\n \n \n Cautionary Statement Regarding Forward Looking Statements\n \n \n The statements in this press release that are not historical facts, and \n may c...